InvestorsHub Logo
Followers 34
Posts 2999
Boards Moderated 0
Alias Born 02/27/2016

Re: sokol post# 88841

Thursday, 01/26/2017 9:05:31 PM

Thursday, January 26, 2017 9:05:31 PM

Post# of 461261
Identifying patients that will benefit. Just as Missling stated in the conference call. Analyzing the super responders and choosing patients in that sub-type. Hence Ariana. Imagine a trial full of super responders.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News